NS

Neelam Singh

Active Director Director DIN 06451397
DIN 06451397 First appointment Aug 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2013
Shareholding value •••• Premium profile

About Neelam Singh

Data last updated:

Neelam Singh is a Director at Balaark Pharmaceuticals Private Limited (since 2013). The company operates in Pharma. Balaark Pharmaceuticals Private Limited reported revenue of ₹2.70 Cr (FY 2025).

DIN 06451397
Primary Designation Director
Industry Pharma
First Appointment 31 Aug 2013
Oldest Company Age 15 yrs
Largest company Balaark Pharmaceuticals Private Limited · ₹2.70 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Aug 20132011₹2.70 Cr (FY 2025)Active

Board colleagues of Neelam Singh

Directorship timeline

Open interactive timeline →
Balaark Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Neelam Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neelam Singh

Neelam Singh currently holds 1 directorship: Balaark Pharmaceuticals Private Limited (Director, since 31 Aug 2013, revenue ₹2.70 Cr (FY 2025)).

Neelam Singh was first appointed on 31 Aug 2013 as Director at Balaark Pharmaceuticals Private Limited.

The current boards of Neelam Singh's companies include Anil Arora (Balaark Pharmaceuticals Private Limited), Archana Singh (Balaark Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available